Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study
Figure 3
Responses to QF2 significantly associated with late discontinuation (Cochran-Armitage trend test). Additional significant associations had trends similar to the questions shown and included: Over the last 6 months, have you experienced any side effects with the drug, Forteo? If yes, were they mild, moderate, or severe? Please think about the physician who is treating you with Forteo: How knowledgeable is the physician about treatment with Forteo?
